BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25304369)

  • 1. The Src homology 3 binding domain is required for lysophosphatidic acid 3 receptor-mediated cellular viability in melanoma cells.
    Jia W; Tran SK; Ruddick CA; Murph MM
    Cancer Lett; 2015 Jan; 356(2 Pt B):589-96. PubMed ID: 25304369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-122-5p Expression and Secretion in Melanoma Cells Is Amplified by the LPAR3 SH3-Binding Domain to Regulate Wnt1.
    Byrnes CC; Jia W; Alshamrani AA; Kuppa SS; Murph MM
    Mol Cancer Res; 2019 Jan; 17(1):299-309. PubMed ID: 30266753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrovipecetin, a C-type lectin from Macrovipera lebetina venom, inhibits proliferation migration and invasion of SK-MEL-28 human melanoma cells and enhances their sensitivity to cisplatin.
    Hammouda MB; Riahi-Chebbi I; Souid S; Othman H; Aloui Z; Srairi-Abid N; Karoui H; Gasmi A; Magnenat EM; Wells TNC; Clemetson KJ; Rodríguez-López JN; Essafi-Benkhadir K
    Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):600-614. PubMed ID: 29196192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells.
    Hayashi M; Okabe K; Kato K; Okumura M; Fukui R; Fukushima N; Tsujiuchi T
    Cancer Lett; 2012 Mar; 316(1):91-6. PubMed ID: 22079467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indole-3-carbinol and ultraviolet B induce apoptosis of human melanoma cells via down-regulation of MITF.
    Kim SY; Kima DS; Jeong YM; Moon SI; Kwon SB; Park KC
    Pharmazie; 2011 Dec; 66(12):982-7. PubMed ID: 22312706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LPA
    Solís KH; Romero-Ávila MT; Rincón-Heredia R; García-Sáinz JA
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.
    Bae SI; Cheriyath V; Jacobs BS; Reu FJ; Borden EC
    Oncogene; 2008 Jan; 27(4):490-8. PubMed ID: 17653094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of six aspartate (D) recombinant mojastin mutants (r-Moj): A second aspartate amino acid carboxyl to the RGD in r-Moj-D_ peptides is not sufficient to induce apoptosis of SK-Mel-28 cells.
    Ramos CJ; Gutierrez DA; Aranda AS; Koshlaychuk MA; Carrillo DA; Medrano R; McBride TD; U A; Medina SM; Lombardo MC; Lucena SE; Sanchez EE; Soto JG
    Toxicon; 2016 Aug; 118():36-42. PubMed ID: 27105671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
    Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
    Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif.
    Lewitzky M; Kardinal C; Gehring NH; Schmidt EK; Konkol B; Eulitz M; Birchmeier W; Schaeper U; Feller SM
    Oncogene; 2001 Mar; 20(9):1052-62. PubMed ID: 11314042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of salmosin, a Korean snake venom-derived disintegrin, on the integrin alphav-mediated proliferation of SK-Mel-2 human melanoma cells.
    Chung KH; Kim SH; Han KY; Sohn YD; Chang SI; Baek KH; Jang Y; Kim DS; Kang IC
    J Pharm Pharmacol; 2003 Nov; 55(11):1577-82. PubMed ID: 14713370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SH3 domain of Itk/Emt binds to proline-rich sequences in the cytoplasmic domain of the T cell costimulatory receptor CD28.
    Marengère LE; Okkenhaug K; Clavreul A; Couez D; Gibson S; Mills GB; Mak TW; Rottapel R
    J Immunol; 1997 Oct; 159(7):3220-9. PubMed ID: 9317120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis of the differential binding of the SH3 domains of Grb2 adaptor to the guanine nucleotide exchange factor Sos1.
    McDonald CB; Seldeen KL; Deegan BJ; Farooq A
    Arch Biochem Biophys; 2008 Nov; 479(1):52-62. PubMed ID: 18778683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of the HLA-A2 antigen loss by melanoma cells SK-MEL-29.1.22 and SK-MEL-29.1.29.
    Wang Z; Seliger B; Mike N; Momburg F; Knuth A; Ferrone S
    Cancer Res; 1998 May; 58(10):2149-57. PubMed ID: 9605759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysophosphatidic Acid Receptor 3 (LPA3): Signaling and Phosphorylation Sites.
    Solís KH; Romero-Ávila MT; Rincón-Heredia R; García-Sáinz JA
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ircinin-1 induces cell cycle arrest and apoptosis in SK-MEL-2 human melanoma cells.
    Choi HJ; Choi YH; Yee SB; Im E; Jung JH; Kim ND
    Mol Carcinog; 2005 Nov; 44(3):162-73. PubMed ID: 16163705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenic analysis of Vav reveals that an intact SH3 domain is required for transformation.
    Groysman M; Nagano M; Shaanan B; Katzav S
    Oncogene; 1998 Sep; 17(12):1597-606. PubMed ID: 9794237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous melanin-concentrating hormone receptor SLC-1 in human melanoma SK-MEL-37 cells.
    Saito Y; Wang Z; Hagino-Yamagishi K; Civelli O; Kawashima S; Maruyama K
    Biochem Biophys Res Commun; 2001 Nov; 289(1):44-50. PubMed ID: 11708774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of reverse transcriptase activity in human melanoma cell lines and identification of a murine leukemia virus contaminant.
    Deichmann M; Huder JB; Kleist C; Näher H; Schüpbach J; Böni J
    Arch Dermatol Res; 2005 Feb; 296(8):345-52. PubMed ID: 15630577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.